Free Trial

Criteo (CRTO) Financials

Criteo logo
$17.66 +0.23 (+1.32%)
As of 12:15 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Criteo

Annual Income Statements for Criteo

This table shows Criteo's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
60 82 91 89 91 72 134 8.95 53 112 145
Consolidated Net Income / (Loss)
62 87 97 96 96 75 138 11 55 115 149
Net Income / (Loss) Continuing Operations
62 87 97 96 96 75 138 11 55 115 149
Total Pre-Tax Income
72 120 128 142 135 107 154 42 75 154 204
Total Operating Income
76 121 138 147 141 109 152 24 77 151 203
Total Gross Profit
472 645 819 834 829 688 782 795 863 983 1,049
Total Revenue
1,323 1,799 2,297 2,300 2,262 2,073 2,254 2,017 1,949 1,933 1,945
Operating Revenue
1,323 1,799 2,297 2,300 2,262 2,073 2,254 2,017 1,949 1,933 1,945
Total Cost of Revenue
851 1,154 1,477 1,466 1,432 1,385 1,472 1,222 1,086 950 896
Operating Cost of Revenue
851 1,154 1,477 1,466 1,432 1,385 1,472 1,222 1,086 950 896
Total Operating Expenses
395 524 682 687 688 579 630 771 786 832 847
Selling, General & Admin Expense
79 117 127 135 140 116 153 205 138 176 169
Marketing Expense
230 283 381 373 375 330 326 378 406 376 394
Research & Development Expense
87 124 174 179 173 133 152 188 242 279 283
Total Other Income / (Expense), net
-4.54 -0.55 -9.53 -5.08 -5.75 -1.94 1.94 18 -2.49 3.10 0.81
Other Income / (Expense), net
-4.54 -0.55 -9.53 -5.08 -5.75 -1.94 1.94 18 -2.49 3.10 0.81
Income Tax Expense
9.52 33 32 46 39 32 16 31 20 40 54
Net Income / (Loss) Attributable to Noncontrolling Interest
2.72 5.06 5.45 7.24 5.22 3.01 3.19 1.92 1.39 3.14 4.78
Basic Earnings per Share
$0.96 $1.30 $1.40 $1.33 $1.41 $1.18 $2.21 $0.15 $0.95 $2.04 $2.73
Weighted Average Basic Shares Outstanding
61.84M 63.34M 65.14M 66.46M 64.31M 60.88M 60.72M 60.00M 56.17M 54.82M 52.93M
Diluted Earnings per Share
$0.91 $1.25 $1.34 $1.31 $1.38 $1.16 $2.09 $0.14 $0.88 $1.90 $2.64
Weighted Average Diluted Shares Outstanding
65.10M 65.63M 67.85M 67.66M 65.60M 61.82M 64.23M 62.76M 60.23M 58.61M 54.79M
Weighted Average Basic & Diluted Shares Outstanding
62M 63.30M 65.20M 67.71M 61.92M 60.76M 60.76M 55.83M 55.23M 54.34M 49.86M

Quarterly Income Statements for Criteo

This table shows Criteo's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
61 7.24 27 6.25 71 38 21 38 7.82 11 5.58
Consolidated Net Income / (Loss)
62 8.57 28 6.14 72 40 23 40 8.58 12 6.13
Net Income / (Loss) Continuing Operations
62 8.57 28 6.14 72 40 23 40 8.58 12 6.13
Total Pre-Tax Income
84 12 37 9.59 97 50 29 52 12 15 22
Total Operating Income
88 10 37 9.60 95 48 30 52 10 15 21
Total Gross Profit
277 217 233 232 301 237 259 256 223 222 208
Total Revenue
566 450 471 459 553 451 483 470 425 428 416
Operating Revenue
566 450 471 459 553 451 483 470 425 428 416
Total Cost of Revenue
290 233 238 227 252 214 224 213 202 206 209
Operating Cost of Revenue
290 233 238 227 252 214 224 213 202 206 209
Total Operating Expenses
188 207 196 222 206 189 228 205 212 207 187
Selling, General & Admin Expense
42 47 41 46 42 39 40 50 45 50 42
Marketing Expense
98 93 95 91 97 89 108 87 98 86 87
Research & Development Expense
48 67 60 85 68 61 80 68 70 72 57
Total Other Income / (Expense), net
-4.50 1.18 -0.28 -0.01 2.21 2.30 -1.80 -0.02 1.87 0.32 1.07
Other Income / (Expense), net
-4.50 1.18 -0.28 -0.01 2.21 2.30 -1.80 -0.02 1.87 0.32 1.07
Income Tax Expense
22 2.97 8.60 3.45 25 10 5.73 12 3.69 3.58 16
Net Income / (Loss) Attributable to Noncontrolling Interest
1.03 1.32 1.07 -0.10 0.85 2.08 1.67 2.30 0.76 0.56 0.55
Basic Earnings per Share
$1.09 $0.13 $0.49 $0.11 $1.31 $0.70 $0.40 $0.72 $0.16 $0.23 $0.11
Weighted Average Basic Shares Outstanding
56.17M 55.15M 54.68M 54.70M 54.82M 53.98M 52.99M 52.57M 50.35M 49.66M 48.87M
Diluted Earnings per Share
$1.02 $0.12 $0.46 $0.11 $1.21 $0.66 $0.39 $0.70 $0.15 $0.22 $0.11
Weighted Average Diluted Shares Outstanding
60.23M 59.33M 58.97M 58.43M 58.61M 57.20M 55.13M 53.76M 50.97M 50.55M 49.80M
Weighted Average Basic & Diluted Shares Outstanding
55.23M 56.69M 55.99M 55.18M 54.34M 53.14M 52.33M - 50.24M 49.00M 49.21M

Annual Cash Flow Statements for Criteo

This table details how cash moves in and out of Criteo's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
43 -69 110 -29 54 69 28 -67 -37 -120 51
Net Cash From Operating Activities
137 153 245 261 223 185 221 256 224 258 311
Net Cash From Continuing Operating Activities
137 153 245 261 223 185 221 256 224 258 311
Net Income / (Loss) Continuing Operations
62 87 97 96 96 75 138 11 55 115 149
Consolidated Net Income / (Loss)
62 87 97 96 96 75 138 11 55 115 149
Amortization Expense
- - - 112 97 107 91 150 72 88 129
Non-Cash Adjustments To Reconcile Net Income
28 43 65 64 42 33 47 41 49 108 65
Changes in Operating Assets and Liabilities, net
-0.52 -39 -20 -10 -12 -29 -54 54 49 -53 -33
Net Cash From Investing Activities
-102 -313 -106 -227 -104 -101 -76 -166 -109 -98 -101
Net Cash From Continuing Investing Activities
-102 -313 -106 -227 -104 -101 -76 -166 -109 -98 -101
Purchase of Property, Plant & Equipment
-76 -85 -122 -125 -98 -65 -53 -64 -116 -78 -103
Acquisitions
-21 - - - - - -10 -138 -6.83 -0.53 0.00
Purchase of Investments
- - - - - - - - -22 -27 -28
Sale of Property, Plant & Equipment
1.13 7.75 14 - - - - 7.97 1.80 1.48 2.01
Divestitures
- - - - - - 0.00 0.00 8.85 0.00 0.00
Sale and/or Maturity of Investments
- - - - - - - 47 26 5.95 28
Net Cash From Financing Activities
7.81 91 -29 -63 -59 -58 -80 -113 -147 -270 -151
Net Cash From Continuing Financing Activities
7.81 91 -29 -63 -59 -58 -80 -113 -147 -270 -151
Repayment of Debt
-8.98 -13 -90 -0.96 -1.02 -167 -1.25 -57 -1.69 1.53 -1.31
Repurchase of Common Equity
- 0.00 0.00 -80 -59 -44 -100 -136 -125 -225 -152
Other Financing Activities, net
-1.00 -0.22 25 17 -1.19 -1.66 -4.04 -0.27 -20 -47 1.90
Effect of Exchange Rate Changes
- - - - -5.50 43 -37 -44 -5.14 -10 -7.21
Cash Interest Paid
- - 2.10 1.70 1.40 2.16 1.49 1.30 1.54 1.36 1.58
Cash Income Taxes Paid
- - -56 67 52 18 29 38 40 41 65

Quarterly Cash Flow Statements for Criteo

This table details how cash moves in and out of Criteo's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
141 -69 -50 -7.79 6.95 -4.77 -80 49 -22 -68 23
Net Cash From Operating Activities
161 14 17 58 169 62 -1.40 90 48 20 57
Net Cash From Continuing Operating Activities
161 14 17 58 169 62 -1.40 90 48 20 57
Net Income / (Loss) Continuing Operations
62 8.57 28 6.14 72 40 23 40 8.58 12 6.13
Consolidated Net Income / (Loss)
62 8.57 28 6.14 72 40 23 40 8.58 12 6.13
Amortization Expense
16 25 21 21 21 24 37 37 29 23 26
Non-Cash Adjustments To Reconcile Net Income
21 30 22 38 19 16 26 15 13 17 9.91
Changes in Operating Assets and Liabilities, net
62 -50 -54 -7.42 58 -18 -87 -1.86 -1.90 -32 15
Net Cash From Investing Activities
-4.51 -14 -21 -24 -39 -18 -24 -27 -38 -58 -36
Net Cash From Continuing Investing Activities
-4.51 -14 -21 -24 -39 -18 -24 -27 -38 -58 -36
Purchase of Property, Plant & Equipment
-38 -14 -24 -19 -22 -17 -35 -23 -33 -58 -36
Purchase of Investments
- -0.67 - - - -11 -5.95 -5.78 -17 - -5.48
Sale and/or Maturity of Investments
- 0.52 - - - 11 17 0.64 12 0.06 5.49
Net Cash From Financing Activities
-22 -62 -40 -52 -116 -55 -48 -11 -31 -31 -4.64
Net Cash From Continuing Financing Activities
-22 -62 -40 -52 -116 -55 -48 -11 -31 -31 -4.64
Repayment of Debt
-0.49 -0.43 -0.38 -0.49 2.83 -0.47 -0.07 -0.29 -0.32 -0.32 -0.55
Repurchase of Common Equity
-22 -62 -40 -55 -67 -56 -48 -11 -31 -30 -4.10
Effect of Exchange Rate Changes
7.05 -7.33 -6.17 11 -7.42 5.22 -6.21 -1.65 -1.07 0.18 6.72
Cash Interest Paid
0.48 0.33 0.33 0.38 0.33 0.24 0.34 0.38 0.53 0.47 0.66
Cash Income Taxes Paid
-1.25 1.17 23 12 4.61 5.92 42 20 4.95 14 16

Annual Balance Sheets for Criteo

This table presents Criteo's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
494 1,211 1,531 1,597 1,790 1,853 1,984 2,349 2,392 2,266 2,201
Total Current Assets
354 743 992 934 1,000 1,065 1,264 1,261 1,312 1,224 1,072
Cash & Equivalents
354 270 414 364 419 488 516 348 336 291 342
Short-Term Investments
- - - - - 0.00 50 25 5.97 26 23
Accounts Receivable
- 397 484 474 482 474 582 709 776 801 582
Prepaid Expenses
- 53 58 53 61 70 73 78 69 105 53
Current Deferred & Refundable Income Taxes
- 2.74 8.88 19 22 11 8.78 24 2.07 1.55 14
Other Current Assets
- 19 26 23 17 21 34 52 48 - 57
Plant, Property, & Equipment, net
82 109 162 184 194 190 140 131 126 107 139
Total Noncurrent Assets
58 360 378 479 596 599 579 957 953 935 990
Long-Term Investments
- - - - 0.00 42 5.00 0.00 17 16 24
Noncurrent Note & Lease Receivables
- 17 20 20 22 18 6.44 5.93 5.29 4.33 8.31
Goodwill
42 209 237 313 317 326 330 515 524 515 536
Intangible Assets
16 103 96 112 87 80 83 176 181 158 152
Noncurrent Deferred & Refundable Income Taxes
- 31 25 34 28 20 35 32 53 81 91
Other Noncurrent Operating Assets
- - - - 142 114 120 228 173 161 180
Total Liabilities & Shareholders' Equity
11 1,211 1,531 1,597 1,790 1,853 1,984 2,349 2,392 2,266 2,201
Total Liabilities
11 601 634 629 752 701 785 1,268 1,280 1,185 1,015
Total Current Liabilities
7.82 520 621 605 610 600 673 1,080 1,140 1,047 845
Accounts Payable
- 366 417 425 390 367 430 743 839 803 566
Accrued Expenses
- - - - - - - 66 1.47 1.88 9.23
Current Deferred & Payable Income Tax Liabilities
- 14 10.00 7.73 3.42 2.63 6.64 13 17 35 28
Current Employee Benefit Liabilities
- 56 66 66 75 85 98 86 113 109 114
Other Taxes Payable
- 45 59 56 50 58 60 58 26 19 15
Other Current Liabilities
7.82 39 69 51 92 87 77 115 143 79 113
Total Noncurrent Liabilities
3.27 82 13 24 142 100 113 188 140 139 171
Noncurrent Deferred & Payable Income Tax Liabilities
- 0.69 2.50 11 9.27 5.30 3.05 3.46 1.08 4.07 5.29
Noncurrent Employee Benefit Liabilities
- 3.22 5.15 5.54 8.49 6.17 5.53 3.71 4.12 4.71 5.71
Other Noncurrent Operating Liabilities
3.27 78 4.95 7.59 124 89 104 181 135 130 160
Total Equity & Noncontrolling Interests
0.00 610 898 968 1,038 1,153 1,198 1,081 1,111 1,081 1,186
Total Preferred & Common Equity
0.00 600 882 944 1,007 1,117 1,163 1,048 1,080 1,049 1,149
Total Common Equity
0.00 600 882 944 1,007 1,117 1,163 1,048 1,080 1,049 1,149
Common Stock
- 490 594 665 671 695 733 737 771 712 708
Retained Earnings
- 198 300 388 452 491 602 578 555 572 631
Treasury Stock
- - 0.00 -79 -75 -86 -132 -174 -162 -125 -121
Accumulated Other Comprehensive Income / (Loss)
- -89 -12 -31 -40 16 -40 -92 -85 -109 -69
Noncontrolling Interest
- 9.75 16 24 31 36 35 33 32 32 37

Quarterly Balance Sheets for Criteo

This table presents Criteo's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
2,191 2,128 2,141 2,206 2,168 2,208 2,128 2,114 2,072 2,011 2,035
Total Current Assets
1,125 1,059 1,075 1,158 1,139 1,140 1,084 1,026 940 873 885
Cash & Equivalents
306 223 195 267 217 209 286 206 320 252 275
Short-Term Investments
21 21 21 11 16 23 27 18 28 28 28
Accounts Receivable
546 573 625 611 633 646 647 668 448 456 454
Prepaid Expenses
- - - - - - - - 70 63 60
Current Deferred & Refundable Income Taxes
119 28 117 145 149 9.79 60 24 13 17 18
Other Current Assets
58 137 42 50 49 177 64 110 61 57 49
Plant, Property, & Equipment, net
146 144 134 117 116 117 106 126 156 168 197
Total Noncurrent Assets
920 926 931 931 913 951 938 962 976 969 953
Long-Term Investments
11 16 16 11 5.35 5.60 16 18 23 23 23
Noncurrent Note & Lease Receivables
4.54 5.31 4.98 5.37 5.44 4.96 4.92 5.38 8.19 8.07 8.02
Goodwill
523 523 519 521 520 527 521 535 533 532 531
Intangible Assets
180 179 174 175 173 170 160 160 149 141 139
Noncurrent Deferred & Refundable Income Taxes
44 52 56 51 46 71 74 70 88 85 77
Other Noncurrent Operating Assets
158 151 162 167 163 173 161 174 175 180 176
Total Liabilities & Shareholders' Equity
2,191 2,128 2,141 2,206 2,168 2,208 2,128 2,114 2,072 2,011 2,035
Total Liabilities
1,141 1,085 1,106 1,134 1,095 1,123 1,028 987 903 847 852
Total Current Liabilities
993 949 961 995 956 975 887 834 737 678 689
Accounts Payable
602 617 669 630 635 630 640 629 448 457 465
Accrued Expenses
67 45 1.61 1.39 1.37 1.60 1.65 4.17 11 12 9.47
Current Deferred & Payable Income Tax Liabilities
17 3.74 1.63 15 3.33 15 31 8.80 22 8.32 1.73
Current Employee Benefit Liabilities
100 100 100 123 94 104 118 90 119 88 76
Other Taxes Payable
60 61 60 93 89 83 22 17 13 12 16
Other Current Liabilities
147 122 129 133 132 140 74 85 123 100 121
Total Noncurrent Liabilities
148 136 145 139 139 148 141 153 166 169 164
Noncurrent Deferred & Payable Income Tax Liabilities
3.88 3.54 3.43 3.17 3.06 3.18 4.20 4.55 5.18 5.13 5.12
Noncurrent Employee Benefit Liabilities
4.14 4.36 4.03 4.36 4.23 4.94 4.83 5.47 5.73 6.04 5.48
Other Noncurrent Operating Liabilities
140 128 137 131 131 140 132 143 155 158 153
Total Equity & Noncontrolling Interests
1,050 1,043 1,035 1,073 1,073 1,086 1,100 1,128 1,169 1,164 1,183
Total Preferred & Common Equity
1,018 1,012 1,005 1,041 1,043 1,051 1,065 1,089 1,133 1,128 1,144
Total Common Equity
1,018 1,012 1,005 1,041 1,043 1,051 1,065 1,089 1,133 1,128 1,144
Common Stock
762 790 813 800 764 731 709 717 701 708 694
Retained Earnings
552 528 504 543 537 557 607 627 636 608 530
Treasury Stock
-211 -214 -212 -204 -154 -153 -159 -191 -126 -109 -3.52
Accumulated Other Comprehensive Income / (Loss)
-85 -91 -100 -97 -104 -83 -93 -64 -77 -80 -77
Noncontrolling Interest
33 31 30 31 30 34 36 39 37 37 39

Annual Metrics And Ratios for Criteo

This table displays calculated financial ratios and metrics derived from Criteo's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
33.89% 35.97% 27.65% 0.16% -1.69% -8.35% 8.76% -10.52% -3.35% -0.83% 0.60%
EBITDA Growth
21.50% 54.10% 26.83% 9.26% -8.38% -8.21% 14.65% -21.42% -23.53% 64.72% 37.47%
EBIT Growth
11.35% 67.79% 6.52% 10.69% -4.62% -21.10% 43.91% -72.66% 77.67% 106.75% 31.77%
NOPAT Growth
71.49% 32.48% 18.37% -4.36% 0.74% -23.99% 78.73% -95.38% 799.53% 99.09% 32.35%
Net Income Growth
32.80% 40.23% 10.68% -0.81% 0.09% -22.17% 84.29% -92.10% 402.47% 109.93% 30.22%
EPS Growth
26.39% 37.36% 7.20% -2.24% 5.34% -15.94% 80.17% -93.30% 528.57% 115.91% 38.95%
Operating Cash Flow Growth
17.95% 11.90% 59.94% 6.22% -14.53% -16.82% 19.18% 15.88% -12.40% 15.12% 20.56%
Free Cash Flow Firm Growth
0.00% -1,027.87% 67.06% 48.82% 509.80% -14.10% 81.33% -137.35% 225.96% -32.66% 142.89%
Invested Capital Growth
69.13% 161.54% 42.42% 24.79% 2.61% 0.59% 0.74% 8.82% -0.78% 10.45% 6.46%
Revenue Q/Q Growth
0.00% 10.42% 4.90% -0.17% -0.77% 0.42% -0.35% -4.22% 0.10% -0.68% 0.00%
EBITDA Q/Q Growth
0.00% 81.14% 14.03% -2.47% 67.87% 119.69% -0.79% -15.01% 39.65% 7.77% 0.00%
EBIT Q/Q Growth
0.00% 19.11% 12.65% -5.24% -2.22% 10.00% 1.32% -38.72% 123.68% 9.11% 0.00%
NOPAT Q/Q Growth
0.00% 1.32% 16.13% -9.76% -0.75% 6.01% 22.87% -85.08% 481.40% 4.58% 0.00%
Net Income Q/Q Growth
0.00% 2.11% 13.68% -9.64% -0.68% 7.71% 25.67% -84.41% 532.31% 9.44% 0.00%
EPS Q/Q Growth
0.00% 0.81% 16.52% -13.82% 6.15% 7.41% 24.40% -86.00% 528.57% 11.11% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 3.34% 3.08% 2.60% -10.54% -7.62% 11.02% 30.24% 19.05% 3.25% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 78.77% -181.92% 135.46% -70.06% 353.91% 48.40% 279.46% -33.55% 0.00%
Invested Capital Q/Q Growth
0.00% 92.32% 6.22% 11.71% 2.31% 43.13% 5.02% -7.05% -6.94% -3.18% 0.00%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
35.66% 35.85% 35.68% 36.27% 36.66% 33.20% 34.69% 39.42% 44.27% 50.84% 53.96%
EBITDA Margin
8.98% 10.18% 10.12% 11.04% 10.28% 10.30% 10.86% 9.54% 7.54% 12.53% 17.12%
Operating Margin
5.77% 6.73% 6.00% 6.40% 6.24% 5.25% 6.74% 1.20% 3.96% 7.83% 10.43%
EBIT Margin
5.43% 6.70% 5.59% 6.17% 5.99% 5.16% 6.82% 2.09% 3.83% 7.99% 10.47%
Profit (Net Income) Margin
4.71% 4.85% 4.21% 4.17% 4.24% 3.60% 6.11% 0.54% 2.80% 5.93% 7.68%
Tax Burden Percent
86.74% 72.50% 75.33% 67.51% 70.84% 69.88% 89.49% 25.86% 73.12% 74.25% 73.38%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
13.26% 27.50% 24.67% 32.49% 29.16% 30.12% 10.51% 74.14% 26.88% 25.75% 26.62%
Return on Invested Capital (ROIC)
64.10% 37.38% 25.23% 18.27% 16.36% 12.24% 21.74% 0.96% 8.30% 15.77% 19.25%
ROIC Less NNEP Spread (ROIC-NNEP)
60.29% 37.94% 27.33% 19.15% 17.40% 12.53% 21.42% 0.01% 8.74% 15.17% 19.09%
Return on Net Nonoperating Assets (RNNOA)
0.00% -8.74% -12.41% -7.99% -6.80% -5.43% -10.03% 0.00% -3.32% -5.30% -6.07%
Return on Equity (ROE)
0.00% 28.64% 12.82% 10.28% 9.57% 6.82% 11.71% 0.95% 4.98% 10.46% 13.18%
Cash Return on Invested Capital (CROIC)
12.73% -51.99% -9.76% -3.78% 13.79% 11.66% 21.00% -7.48% 9.08% 5.83% 12.99%
Operating Return on Assets (OROA)
15.29% 14.12% 9.36% 9.08% 8.00% 5.87% 8.02% 1.94% 3.15% 6.63% 9.11%
Return on Assets (ROA)
13.26% 10.24% 7.05% 6.13% 5.67% 4.10% 7.17% 0.50% 2.31% 4.93% 6.69%
Return on Common Equity (ROCE)
0.00% 28.18% 12.60% 10.06% 9.31% 6.61% 11.36% 0.93% 4.84% 10.16% 12.78%
Return on Equity Simple (ROE_SIMPLE)
0.00% 14.55% 10.97% 10.16% 9.53% 6.69% 11.83% 1.04% 5.06% 10.93% 0.00%
Net Operating Profit after Tax (NOPAT)
66 88 104 99 100 76 136 6.28 56 112 149
NOPAT Margin
5.00% 4.88% 4.52% 4.32% 4.42% 3.67% 6.03% 0.31% 2.90% 5.81% 7.65%
Net Nonoperating Expense Percent (NNEP)
3.81% -0.56% -2.10% -0.88% -1.04% -0.29% 0.32% 0.95% -0.44% 0.60% 0.16%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 0.58% 5.08% 10.40% 12.55%
Cost of Revenue to Revenue
64.34% 64.15% 64.32% 63.73% 63.34% 66.80% 65.31% 60.58% 55.73% 49.16% 46.04%
SG&A Expenses to Revenue
5.98% 6.53% 5.53% 5.88% 6.18% 5.62% 6.77% 10.18% 7.05% 9.11% 8.69%
R&D to Revenue
6.56% 6.87% 7.57% 7.79% 7.63% 6.39% 6.73% 9.30% 12.43% 14.45% 14.57%
Operating Expenses to Revenue
29.89% 29.12% 29.68% 29.87% 30.41% 27.95% 27.95% 38.22% 40.31% 43.01% 43.53%
Earnings before Interest and Taxes (EBIT)
72 120 128 142 135 107 154 42 75 154 204
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
119 183 232 254 233 213 245 192 147 242 333
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 4.36 1.95 1.62 1.10 1.11 2.03 1.50 1.32 2.08 0.94
Price to Tangible Book Value (P/TBV)
0.00 9.10 3.13 2.95 1.84 1.74 3.14 4.40 3.81 5.81 2.34
Price to Revenue (P/Rev)
0.00 1.46 0.75 0.67 0.49 0.60 1.05 0.78 0.73 1.13 0.55
Price to Earnings (P/E)
0.00 31.84 18.83 17.27 12.24 17.24 17.55 175.28 26.82 19.57 7.46
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 3.14% 5.31% 5.79% 8.17% 5.80% 5.70% 0.57% 3.73% 5.11% 13.41%
Enterprise Value to Invested Capital (EV/IC)
0.00 6.95 2.73 1.97 1.17 1.19 2.91 1.76 1.52 2.52 0.91
Enterprise Value to Revenue (EV/Rev)
0.00 1.31 0.57 0.52 0.32 0.36 0.81 0.60 0.53 0.97 0.37
Enterprise Value to EBITDA (EV/EBITDA)
0.00 12.88 5.68 4.69 3.11 3.47 7.46 6.26 6.98 7.77 2.18
Enterprise Value to EBIT (EV/EBIT)
0.00 19.58 10.29 8.38 5.33 6.94 11.86 28.62 13.74 12.18 3.57
Enterprise Value to NOPAT (EV/NOPAT)
0.00 26.89 12.71 11.99 7.22 9.75 13.43 191.78 18.18 16.74 4.88
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 15.37 5.38 4.57 3.24 4.00 8.26 4.70 4.58 7.29 2.33
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 8.57 10.24 13.90 0.00 16.62 45.25 7.23
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
0.00 -0.23 -0.45 -0.42 -0.39 -0.43 -0.47 -0.43 -0.38 -0.35 -0.32
Leverage Ratio
0.00 2.80 1.82 1.68 1.69 1.66 1.63 1.90 2.16 2.12 1.97
Compound Leverage Factor
0.00 2.80 1.82 1.68 1.69 1.66 1.63 1.90 2.16 2.12 1.97
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 1.60% 1.80% 2.50% 2.96% 3.08% 2.94% 3.06% 2.86% 2.95% 3.08%
Common Equity to Total Capital
0.00% 98.40% 98.20% 97.50% 97.04% 96.92% 97.06% 96.94% 97.14% 97.05% 96.92%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
0.00 4.88 3.97 3.78 3.01 3.04 3.98 2.10 2.00 2.63 2.35
Noncontrolling Interest Sharing Ratio
0.00% 1.60% 1.72% 2.17% 2.74% 3.02% 3.01% 2.99% 2.96% 2.91% 3.02%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
45.19 1.43 1.60 1.54 1.64 1.77 1.88 1.17 1.15 1.17 1.27
Quick Ratio
45.19 1.28 1.45 1.38 1.48 1.60 1.71 1.00 0.98 1.07 1.12
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
13 -122 -40 -21 84 72 131 -49 62 42 100
Operating Cash Flow to CapEx
184.15% 198.33% 226.21% 207.79% 227.52% 283.12% 416.74% 458.38% 196.17% 336.87% 308.99%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
2.82 2.11 1.67 1.47 1.34 1.14 1.18 0.93 0.82 0.83 0.87
Accounts Receivable Turnover
0.00 0.00 5.21 4.80 4.73 4.34 4.27 3.12 2.63 2.45 2.81
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
19.64 18.83 16.99 13.31 11.96 10.80 13.68 14.88 15.13 16.54 15.78
Accounts Payable Turnover
0.00 0.00 3.77 3.48 3.51 3.66 3.69 2.08 1.37 1.16 1.31
Days Sales Outstanding (DSO)
0.00 0.00 70.03 76.01 77.12 84.16 85.50 116.81 138.98 148.81 129.77
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 96.71 104.86 103.92 99.82 98.83 175.23 265.66 315.15 278.90
Cash Conversion Cycle (CCC)
0.00 0.00 -26.68 -28.86 -26.80 -15.66 -13.33 -58.43 -126.68 -166.33 -149.13
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
130 340 484 603 619 623 627 683 678 748 797
Invested Capital Turnover
12.81 7.67 5.58 4.23 3.70 3.34 3.61 3.08 2.87 2.71 2.52
Increase / (Decrease) in Invested Capital
53 210 144 120 16 3.64 4.63 55 -5.30 71 48
Enterprise Value (EV)
0.00 2,359 1,320 1,190 722 741 1,825 1,204 1,026 1,882 726
Market Capitalization
0.00 2,619 1,718 1,530 1,110 1,236 2,360 1,569 1,429 2,183 1,078
Book Value per Share
$0.00 $9.41 $13.36 $14.01 $15.72 $18.54 $19.15 $17.41 $19.14 $19.01 $21.96
Tangible Book Value per Share
($0.95) $4.51 $8.31 $7.70 $9.41 $11.81 $12.36 $5.93 $6.64 $6.81 $8.82
Total Capital
0.00 610 898 968 1,038 1,153 1,198 1,081 1,111 1,081 1,186
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-354 -270 -414 -364 -419 -530 -571 -398 -434 -333 -389
Capital Expenditures (CapEx)
74 77 109 125 98 65 53 56 114 77 101
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-7.82 -48 -43 -36 -29 -24 26 -217 -245 -140 -138
Debt-free Net Working Capital (DFNWC)
346 223 371 329 390 464 592 181 172 178 227
Net Working Capital (NWC)
346 223 371 329 390 464 592 181 172 178 227
Net Nonoperating Expense (NNE)
3.94 0.40 7.18 3.43 4.07 1.35 -1.74 -4.60 1.82 -2.30 -0.59
Net Nonoperating Obligations (NNO)
130 -270 -414 -364 -419 -530 -571 -398 -434 -333 -389
Total Depreciation and Amortization (D&A)
47 63 104 112 97 107 91 150 72 88 129
Debt-free, Cash-free Net Working Capital to Revenue
-0.59% -2.64% -1.89% -1.56% -1.27% -1.15% 1.14% -10.77% -12.58% -7.22% -7.10%
Debt-free Net Working Capital to Revenue
26.13% 12.38% 16.14% 14.28% 17.25% 22.40% 26.24% 8.97% 8.83% 9.18% 11.68%
Net Working Capital to Revenue
26.13% 12.38% 16.14% 14.28% 17.25% 22.40% 26.24% 8.97% 8.83% 9.18% 11.68%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.96 $1.30 $1.40 $1.33 $1.41 $1.18 $2.21 $0.15 $0.95 $2.04 $2.73
Adjusted Weighted Average Basic Shares Outstanding
61.84M 63.34M 65.14M 66.46M 64.31M 60.88M 60.72M 60.00M 56.17M 54.82M 52.93M
Adjusted Diluted Earnings per Share
$0.91 $1.25 $1.34 $1.31 $1.38 $1.16 $2.09 $0.14 $0.88 $1.90 $2.64
Adjusted Weighted Average Diluted Shares Outstanding
65.10M 65.63M 67.85M 67.66M 65.60M 61.82M 64.23M 62.76M 60.23M 58.61M 54.79M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $1.41 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
62M 63.99M 66.14M 67.71M 61.92M 60.76M 60.76M 55.83M 55.23M 54.34M 49.86M
Normalized Net Operating Profit after Tax (NOPAT)
66 88 104 99 100 76 136 17 56 112 149
Normalized NOPAT Margin
5.00% 4.88% 4.52% 4.32% 4.42% 3.67% 6.03% 0.84% 2.90% 5.81% 7.65%
Pre Tax Income Margin
5.43% 6.70% 5.59% 6.17% 5.99% 5.16% 6.82% 2.09% 3.83% 7.99% 10.47%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 83.44% 61.05% 58.45% 72.67% 1,247.68% 229.65% 195.79% 101.80%

Quarterly Metrics And Ratios for Criteo

This table displays calculated financial ratios and metrics derived from Criteo's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - 52,327,360.00 49,859,086.00 50,244,527.00 48,997,559.00
DEI Adjusted Shares Outstanding
- - - - - - - 52,327,360.00 49,859,086.00 50,244,527.00 48,997,559.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - 0.72 0.16 0.22 0.11
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.33% 1.13% 0.51% -2.20% -2.34% 0.31% 2.41% 2.35% -5.94% -11.32% -11.33%
EBITDA Growth
71.86% 245.42% 526.42% 11.24% 17.49% 101.39% 13.53% 190.23% -44.85% -40.82% -45.12%
EBIT Growth
97.22% 169.21% 4,204.59% 13.31% 15.38% 337.53% -21.83% 437.92% -75.68% -46.51% -57.33%
NOPAT Growth
255.93% 146.76% 4,112.19% -31.37% 7.53% 396.63% -13.85% 552.02% -80.96% -52.77% -85.45%
Net Income Growth
286.63% 170.96% 1,523.59% -7.40% 15.94% 367.09% -18.32% 552.29% -78.56% -48.73% -84.70%
EPS Growth
264.29% 157.14% 1,020.00% -8.33% 18.63% 450.00% -15.22% 536.36% -77.27% -43.59% -84.29%
Operating Cash Flow Growth
28.60% -66.60% 1,194.20% 193.17% 5.03% 344.75% -108.13% 55.82% -22.67% 1,553.04% -36.45%
Free Cash Flow Firm Growth
291.32% 11.93% 85.80% -349.57% -100.74% 62.26% -326.34% 2,198.13% 16.68% 135.97% -204.71%
Invested Capital Growth
-0.78% 11.17% 7.39% 6.17% 10.45% 8.77% 16.68% 0.00% 3.53% -2.85% 0.00%
Revenue Q/Q Growth
20.70% -20.53% 4.72% -2.63% 20.52% -18.37% 6.92% -2.70% 0.00% 0.80% -2.70%
EBITDA Q/Q Growth
265.38% -63.18% 57.04% -47.35% 285.92% -36.89% -11.47% 34.61% 0.00% -5.00% 24.81%
EBIT Q/Q Growth
889.96% -86.24% 217.76% -73.83% 908.07% -47.82% -43.22% 80.11% 0.00% 24.88% 43.68%
NOPAT Q/Q Growth
629.69% -88.24% 267.75% -78.25% 1,043.30% -45.68% -36.21% 64.58% 0.00% 58.26% -49.31%
Net Income Q/Q Growth
835.21% -86.20% 227.56% -78.10% 1,070.96% -44.39% -42.72% 74.86% 0.00% 36.96% -47.83%
EPS Q/Q Growth
750.00% -88.12% 283.33% -76.09% 1,000.00% -45.45% -40.91% 79.49% 0.00% 46.67% -50.00%
Operating Cash Flow Q/Q Growth
722.58% -91.31% 22.62% 234.57% 194.69% -63.21% -102.24% 6,513.74% 0.00% -57.89% 180.52%
Free Cash Flow Firm Q/Q Growth
355.26% -189.88% 62.22% -61.43% 98.66% -4,510.69% -326.83% 894.43% 0.00% 284.25% -2,412.69%
Invested Capital Q/Q Growth
-6.94% 4.60% 7.19% 1.74% -3.18% 3.01% 14.98% -100.00% 0.00% 7.89% -0.46%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
48.85% 48.27% 49.40% 50.54% 54.42% 52.49% 53.56% 54.61% 52.45% 51.92% 49.86%
EBITDA Margin
17.64% 8.17% 12.25% 6.63% 21.22% 16.40% 13.58% 18.79% 9.62% 9.06% 11.63%
Operating Margin
15.60% 2.30% 7.84% 2.09% 17.09% 10.67% 6.31% 10.99% 2.45% 3.51% 5.03%
EBIT Margin
14.80% 2.56% 7.78% 2.09% 17.49% 11.18% 5.94% 10.99% 2.89% 3.58% 5.29%
Profit (Net Income) Margin
10.96% 1.90% 5.95% 1.34% 13.01% 8.86% 4.75% 8.53% 2.02% 2.75% 1.47%
Tax Burden Percent
74.03% 74.26% 76.55% 64.04% 74.39% 79.28% 79.99% 77.66% 69.91% 76.67% 27.84%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
25.97% 25.74% 23.45% 35.96% 25.61% 20.72% 20.01% 22.34% 30.09% 23.33% 72.16%
Return on Invested Capital (ROIC)
33.09% 4.96% 16.01% 3.48% 34.47% 22.12% 11.93% 0.00% 4.19% 5.73% 5.92%
ROIC Less NNEP Spread (ROIC-NNEP)
33.89% 4.74% 16.07% 3.48% 34.04% 21.60% 12.45% 0.00% 3.81% 5.64% 5.73%
Return on Net Nonoperating Assets (RNNOA)
-12.86% -1.73% -4.93% -1.02% -11.90% -6.89% -3.14% 0.00% -1.18% -1.34% -1.58%
Return on Equity (ROE)
20.23% 3.23% 11.08% 2.46% 22.57% 15.23% 8.80% 0.00% 3.01% 4.39% 4.34%
Cash Return on Invested Capital (CROIC)
9.08% 1.49% 7.90% 8.34% 5.83% 10.92% 1.49% 0.00% 11.53% 14.92% -183.50%
Operating Return on Assets (OROA)
12.17% 2.28% 7.08% 1.87% 14.52% 9.98% 5.40% 0.00% 2.64% 3.24% 4.70%
Return on Assets (ROA)
9.01% 1.69% 5.42% 1.20% 10.80% 7.91% 4.32% 0.00% 1.85% 2.48% 1.31%
Return on Common Equity (ROCE)
19.63% 3.13% 10.75% 2.39% 21.91% 14.76% 8.52% 0.00% 2.91% 4.25% 4.20%
Return on Equity Simple (ROE_SIMPLE)
0.00% 7.23% 10.10% 9.97% 0.00% 13.73% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
65 7.69 28 6.15 70 38 24 40 7.27 12 5.83
NOPAT Margin
11.55% 1.71% 6.00% 1.34% 12.71% 8.46% 5.05% 8.54% 1.71% 2.69% 1.40%
Net Nonoperating Expense Percent (NNEP)
-0.80% 0.23% -0.07% 0.00% 0.43% 0.53% -0.52% 0.00% 0.37% 0.09% 0.18%
Return On Investment Capital (ROIC_SIMPLE)
5.88% - - - 6.50% 3.47% 2.16% - 0.62% 0.99% 0.49%
Cost of Revenue to Revenue
51.15% 51.73% 50.60% 49.46% 45.58% 47.51% 46.44% 45.39% 47.55% 48.08% 50.14%
SG&A Expenses to Revenue
7.46% 10.48% 8.74% 10.07% 7.51% 8.68% 8.34% 10.68% 10.63% 11.62% 10.15%
R&D to Revenue
8.55% 14.86% 12.65% 18.59% 12.22% 13.46% 16.49% 14.41% 16.41% 16.81% 13.74%
Operating Expenses to Revenue
33.25% 45.97% 41.57% 48.45% 37.33% 41.82% 47.25% 43.62% 50.01% 48.41% 44.83%
Earnings before Interest and Taxes (EBIT)
84 12 37 9.59 97 50 29 52 12 15 22
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
100 37 58 30 117 74 66 88 41 39 48
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.32 1.90 2.05 2.14 2.08 1.81 1.17 0.00 0.79 0.00 0.65
Price to Tangible Book Value (P/TBV)
3.81 5.73 6.11 6.36 5.81 5.02 3.23 0.00 1.98 0.00 1.57
Price to Revenue (P/Rev)
0.73 1.01 1.09 1.16 1.13 0.99 0.65 0.00 0.47 0.00 0.41
Price to Earnings (P/E)
26.82 27.36 20.93 22.20 19.57 13.53 9.33 0.00 7.81 0.00 10.31
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
3.73% 3.65% 4.78% 4.51% 5.11% 7.39% 10.72% 0.00% 12.81% 0.00% 9.70%
Enterprise Value to Invested Capital (EV/IC)
1.52 2.32 2.44 2.55 2.52 2.12 1.21 0.00 0.70 0.00 0.53
Enterprise Value to Revenue (EV/Rev)
0.53 0.84 0.95 1.01 0.97 0.84 0.55 0.00 0.29 0.00 0.25
Enterprise Value to EBITDA (EV/EBITDA)
6.98 9.50 8.37 8.78 7.77 5.83 3.73 0.00 1.87 0.00 1.96
Enterprise Value to EBIT (EV/EBIT)
13.74 15.99 13.21 13.94 12.18 8.43 5.77 0.00 3.38 0.00 3.74
Enterprise Value to NOPAT (EV/NOPAT)
18.18 20.26 16.83 18.37 16.74 11.40 7.70 0.00 4.75 0.00 6.47
Enterprise Value to Operating Cash Flow (EV/OCF)
4.58 8.38 8.74 7.90 7.29 5.32 3.72 0.00 1.88 0.00 1.60
Enterprise Value to Free Cash Flow (EV/FCFF)
16.62 164.35 32.01 31.54 45.25 20.18 87.27 0.00 6.18 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.38 -0.37 -0.31 -0.29 -0.35 -0.32 -0.25 0.00 -0.31 -0.24 -0.28
Leverage Ratio
2.16 2.07 2.03 2.05 2.12 1.99 1.95 0.00 1.85 1.80 1.72
Compound Leverage Factor
2.16 2.07 2.03 2.05 2.12 1.99 1.95 0.00 1.85 1.80 1.72
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
2.86% 2.90% 2.83% 3.14% 2.95% 3.24% 3.42% 0.00% 3.13% 3.15% 3.26%
Common Equity to Total Capital
97.14% 97.10% 97.17% 96.86% 97.05% 96.76% 96.58% 0.00% 96.87% 96.85% 96.74%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
2.01 2.38 2.58 2.54 2.55 2.62 2.26 0.00 2.09 0.00 1.93
Noncontrolling Interest Sharing Ratio
2.96% 3.00% 2.89% 3.01% 2.91% 3.07% 3.13% 0.00% 3.18% 3.28% 3.26%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.15 1.16 1.19 1.17 1.17 1.22 1.23 0.00 1.28 1.29 1.29
Quick Ratio
0.98 0.89 0.91 0.90 1.07 1.08 1.07 0.00 1.08 1.09 1.10
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
71 -64 -24 -39 -0.52 -24 -102 813 -20 37 -851
Operating Cash Flow to CapEx
817.99% 106.00% 81.38% 304.26% 724.35% 364.76% -4.00% 402.55% 149.68% 35.11% 158.84%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.82 0.89 0.91 0.90 0.83 0.89 0.91 0.00 0.91 0.90 0.89
Accounts Receivable Turnover
2.63 3.38 3.24 3.06 2.45 3.08 2.99 0.00 3.50 3.32 3.99
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
15.13 14.86 15.08 15.50 16.54 17.39 16.07 0.00 14.69 12.64 9.19
Accounts Payable Turnover
1.37 1.71 1.64 1.52 1.16 1.47 1.45 0.00 1.62 1.59 1.85
Days Sales Outstanding (DSO)
138.98 107.99 112.49 119.15 148.81 118.65 121.96 0.00 104.22 110.05 91.58
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
265.66 212.94 222.87 239.88 315.15 248.59 251.39 0.00 224.94 229.22 197.09
Cash Conversion Cycle (CCC)
-126.68 -104.95 -110.38 -120.73 -166.33 -129.94 -129.43 0.00 -120.72 -119.16 -105.51
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
678 709 760 773 748 771 886 0.00 798 861 857
Invested Capital Turnover
2.87 2.90 2.67 2.59 2.71 2.62 2.36 0.00 2.45 2.13 4.22
Increase / (Decrease) in Invested Capital
-5.30 71 52 45 71 62 127 -773 27 -25 857
Enterprise Value (EV)
1,026 1,646 1,855 1,974 1,882 1,631 1,071 0.00 559 0.00 458
Market Capitalization
1,429 1,979 2,138 2,253 2,183 1,924 1,273 0.00 894 0.00 745
Book Value per Share
$19.14 $18.88 $18.40 $18.78 $19.01 $19.59 $20.49 $0.00 $22.72 $22.44 $23.35
Tangible Book Value per Share
$6.64 $6.26 $6.18 $6.33 $6.81 $7.05 $7.41 $0.00 $9.06 $9.04 $9.68
Total Capital
1,111 1,073 1,073 1,086 1,081 1,100 1,128 0.00 1,169 1,164 1,183
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-434 -364 -314 -313 -333 -329 -241 0.00 -371 -303 -326
Capital Expenditures (CapEx)
20 13 21 19 23 17 35 22 32 58 36
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-245 -190 -125 -141 -140 -116 -31 0.00 -145 -85 -106
Debt-free Net Working Capital (DFNWC)
172 163 183 166 178 197 192 0.00 203 195 196
Net Working Capital (NWC)
172 163 183 166 178 197 192 0.00 203 195 196
Net Nonoperating Expense (NNE)
3.33 -0.88 0.22 0.01 -1.64 -1.82 1.44 0.02 -1.31 -0.24 -0.30
Net Nonoperating Obligations (NNO)
-434 -364 -314 -313 -333 -329 -241 0.00 -371 -303 -326
Total Depreciation and Amortization (D&A)
16 25 21 21 21 24 37 37 29 23 26
Debt-free, Cash-free Net Working Capital to Revenue
-12.58% -9.70% -6.39% -7.26% -7.22% -6.00% -1.60% 0.00% -7.56% -4.56% -5.88%
Debt-free Net Working Capital to Revenue
8.83% 8.36% 9.36% 8.51% 9.18% 10.19% 9.89% 0.00% 10.60% 10.48% 10.85%
Net Working Capital to Revenue
8.83% 8.36% 9.36% 8.51% 9.18% 10.19% 9.89% 0.00% 10.60% 10.48% 10.85%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.09 $0.13 $0.49 $0.11 $1.31 $0.70 $0.40 $0.00 $0.16 $0.23 $0.11
Adjusted Weighted Average Basic Shares Outstanding
56.17M 55.15M 54.68M 54.70M 54.82M 53.98M 52.99M 0.00 50.35M 49.66M 48.87M
Adjusted Diluted Earnings per Share
$1.02 $0.12 $0.46 $0.11 $1.21 $0.66 $0.39 $0.00 $0.15 $0.22 $0.11
Adjusted Weighted Average Diluted Shares Outstanding
60.23M 59.33M 58.97M 58.43M 58.61M 57.20M 55.13M 0.00 50.97M 50.55M 49.80M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
55.23M 56.69M 55.99M 55.18M 54.34M 53.14M 52.33M 0.00 50.24M 49.00M 49.21M
Normalized Net Operating Profit after Tax (NOPAT)
65 7.69 28 6.15 70 38 24 40 7.27 12 15
Normalized NOPAT Margin
11.55% 1.71% 6.00% 1.34% 12.71% 8.46% 5.05% 8.54% 1.71% 2.69% 3.52%
Pre Tax Income Margin
14.80% 2.56% 7.78% 2.09% 17.49% 11.18% 5.94% 10.99% 2.89% 3.58% 5.29%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
229.65% 181.46% 145.40% 171.37% 195.79% 149.58% 160.68% 104.34% 107.56% 101.98% 140.10%

Financials Breakdown Chart

Key Financial Trends

Criteo’s Q2 2026 results show improving cash generation and balance-sheet strength, but weaker revenue and profitability remain important concerns. Revenue was $428.0 million, down 11.3% from the restated $482.7 million reported in Q2 2025 and below the $471.3 million recorded in Q2 2024. Revenue did edge up from $424.6 million in Q1 2026, suggesting modest sequential stabilization.

Profitability has also deteriorated compared with the prior year. Gross profit declined to $222.2 million from $258.5 million, while the gross margin fell to approximately 51.9% from 53.5%. Operating income dropped to $15.0 million from $30.5 million, reducing the operating margin to 3.5% from 6.3%. Net income attributable to common shareholders fell to $11.2 million, or $0.22 per diluted share, compared with $21.3 million, or $0.39 per diluted share, in Q2 2025.

The longer-term trend is mixed. Criteo moved from a $23.5 million operating loss in Q1 2023 to positive operating income in subsequent periods, including $94.5 million in Q4 2024. However, quarterly operating income has since moderated to $48.2 million in Q1 2025, $30.5 million in Q2 2025, $10.4 million in Q1 2026 and $15.0 million in Q2 2026. This indicates that the company has remained profitable but has not yet restored its earlier margin levels.

Cash flow improved substantially year over year. Operating cash flow was $20.3 million in Q2 2026, compared with negative $1.4 million in Q2 2025 and $17.2 million in Q2 2024. Still, operating cash flow declined from $48.2 million in Q1 2026. Q2 cash generation benefited from $23.5 million of amortization and other noncash adjustments, while changes in operating assets and liabilities reduced cash flow by $31.8 million. Investors should therefore monitor whether cash generation improves through recurring earnings rather than primarily through noncash add-backs.

  • Operating cash flow returned to positive territory: Q2 2026 operating cash flow of $20.3 million compared favorably with the $1.4 million outflow in Q2 2025.
  • Liquidity remains solid: Cash and equivalents plus short-term investments totaled approximately $280.3 million at June 30, 2026, up from roughly $224.6 million a year earlier.
  • Lower liabilities strengthened the balance sheet: Total liabilities declined to $846.7 million from $986.6 million in Q2 2025, while total equity and noncontrolling interests increased to $1.16 billion.
  • Working-capital exposure improved year over year: Accounts receivable fell to $456.0 million from $667.8 million, which may reflect improved collections, lower revenue volume or both.
  • Share count continued to decline: Basic weighted-average shares fell to 49.7 million from 53.0 million in Q2 2025, supported by ongoing share repurchases and potentially beneficial to per-share results over time.
  • Sequential profitability improved: Q2 2026 operating income and common-shareholder net income increased from Q1 2026, indicating some stabilization after a weak start to the year.
  • Capital spending increased materially: Purchases of property, plant and equipment rose to $58.2 million in Q2 2026 from $32.8 million in Q1 and $35.3 million in Q2 2025. This could support future growth, but it consumed substantially more cash in the near term.
  • Free cash flow was pressured: Operating cash flow did not cover capital expenditures, share repurchases and other financing uses, resulting in a $68.0 million quarterly decline in cash.
  • Revenue remains below recent historical levels: Q2 2026 revenue was below Q2 2023, Q2 2024 and Q2 2025, indicating that the company has not yet returned to its prior growth trajectory.
  • Margins and earnings weakened: Q2 2026 operating income and diluted EPS were approximately half their Q2 2025 levels, while marketing, research and development, and other operating costs remained substantial relative to revenue.

Criteo’s current ratio was approximately 1.3 at the end of Q2 2026, an improvement from about 1.2 a year earlier. The company also reported only modest debt repayment activity, and interest expense remained low. However, goodwill and intangible assets totaled approximately $673.2 million, or about one-third of total assets, creating potential impairment risk if operating performance weakens further.

Overall, the statements point to a company with meaningful liquidity, lower liabilities and recurring share buybacks, but with a fragile earnings profile. The most important issues for investors are whether revenue can reaccelerate, whether operating margins can recover and whether higher capital spending will produce stronger future cash returns.

11/13/26 12:16 PM ETAI Generated. May Contain Errors.

Criteo Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Criteo's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Criteo's net income appears to be on an upward trend, with a most recent value of $149.38 million in 2025, rising from $62.28 million in 2015. The previous period was $114.71 million in 2024. See where experts think Criteo is headed by visiting Criteo's forecast page.

Criteo's total operating income in 2025 was $202.77 million, based on the following breakdown:
  • Total Gross Profit: $1.05 billion
  • Total Operating Expenses: $846.62 million

Over the last 10 years, Criteo's total revenue changed from $1.32 billion in 2015 to $1.94 billion in 2025, a change of 47.0%.

In the past 14 quarters, Criteo's cash and equivalents has ranged from $194.86 million in Q3 2023 to $319.98 million in Q1 2026, and is currently $274.84 million as of their latest financial filing in Q3 2026.

Criteo had total debt of $0.00 at the end of 2025, compared with none in 2024, and none in 2015.

Over the last 10 years, Criteo's book value per share changed from 0.00 in 2015 to 21.96 in 2025, a change of 2,196.2%.



Financial statements for NASDAQ:CRTO last updated on 11/4/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners